123 related articles for article (PubMed ID: 19222333)
41. Gastrointestinal stromal tumors: A multicenter study of 1160 Turkish cases.
Bülbül Doğusoy G;
Turk J Gastroenterol; 2012 Jun; 23(3):203-11. PubMed ID: 22798108
[TBL] [Abstract][Full Text] [Related]
42. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.
Sui XL; Wang H; Sun XW
Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337
[TBL] [Abstract][Full Text] [Related]
43. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade.
Hasegawa T; Matsuno Y; Shimoda T; Hirohashi S
Hum Pathol; 2002 Jun; 33(6):669-76. PubMed ID: 12152168
[TBL] [Abstract][Full Text] [Related]
44. A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor.
Li H; Ren G; Cai R; Chen J; Wu X; Zhao J
Cancer Med; 2018 Sep; 7(9):4467-4474. PubMed ID: 30123969
[TBL] [Abstract][Full Text] [Related]
45. [Gastrointestinal stromal tumors (GISTs): clinical and pathological features].
Kovács M; Nagy P; Pák G; Fehér J
Orv Hetil; 2005 Jun; 146(26):1375-81. PubMed ID: 16052979
[TBL] [Abstract][Full Text] [Related]
46. Protein S100 as prognostic marker for gastrointestinal stromal tumors: a clinicopathological risk factor analysis.
Perez D; Demartines N; Meier K; Clavien PA; Jungbluth A; Jaeger D
J Invest Surg; 2007; 20(3):181-6. PubMed ID: 17613693
[TBL] [Abstract][Full Text] [Related]
47. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
48. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases.
Miettinen M; Monihan JM; Sarlomo-Rikala M; Kovatich AJ; Carr NJ; Emory TS; Sobin LH
Am J Surg Pathol; 1999 Sep; 23(9):1109-18. PubMed ID: 10478672
[TBL] [Abstract][Full Text] [Related]
49. [Imaging and pathological features of gastrointestinal stromal tumors].
Song T; Shen J; Guo HC; Liang BL; Pan H; Jiang KM; Xian JX
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):386-90. PubMed ID: 17892139
[TBL] [Abstract][Full Text] [Related]
50. The Relationship of Clinicopathological Findings and PDGFR-β Expression With Tumor Recurrence in Gastrointestinal Stromal Tumors.
Kaymaz E; Taşdöven İ; Barut F
Turk J Gastroenterol; 2021 Dec; 32(12):1038-1048. PubMed ID: 34876394
[TBL] [Abstract][Full Text] [Related]
51. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.
Miettinen M; Makhlouf H; Sobin LH; Lasota J
Am J Surg Pathol; 2006 Apr; 30(4):477-89. PubMed ID: 16625094
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
53. [Analysis of prognostic and clinicopathologic factors in gastrointestinal stromal tumors of the stomach].
Bai YK; Shao YF; Cao WL; Shi SS; Yu LW
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):21-5. PubMed ID: 17253167
[TBL] [Abstract][Full Text] [Related]
54. [Gastrointestinal stromal tumors: clinicopathologic and survival evaluation in Rebagliati Hospital].
Manrique MN; Soriano C; Yábar A; Frisancho O; Palacios AM
Rev Gastroenterol Peru; 2012; 32(4):357-65. PubMed ID: 23307085
[TBL] [Abstract][Full Text] [Related]
55. [A clinicopathologic and immunohistochemical study on 76 cases of gastrointestinal stromal tumors].
Hou Y; Wang J; Zhu X; Du X; Sun M; Zheng A
Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):20-5. PubMed ID: 11955330
[TBL] [Abstract][Full Text] [Related]
56. Giant gastrointestinal stromal tumor of the stomach.
Ionescu S; Barbu E; Ionescu C; Costache A; Bălăşoiu M
Rom J Morphol Embryol; 2015; 56(1):239-45. PubMed ID: 25826510
[TBL] [Abstract][Full Text] [Related]
57. Gastrointestinal stromal tumors - a clinical-morphological study on 15 cases.
Pleşea IE; Chiuţu L; Bordu SI; Georgescu I; Georgescu EF; Ciobanu D; Mărgăritescu ND; Comănescu V; Nemeş R
Rom J Morphol Embryol; 2014; 55(2 Suppl):513-23. PubMed ID: 25178321
[TBL] [Abstract][Full Text] [Related]
58. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
59. Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors.
Lin SC; Huang MJ; Zeng CY; Wang TI; Liu ZL; Shiay RK
World J Gastroenterol; 2003 Dec; 9(12):2809-12. PubMed ID: 14669339
[TBL] [Abstract][Full Text] [Related]
60. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
Ihle MA; Huss S; Jeske W; Hartmann W; Merkelbach-Bruse S; Schildhaus HU; Büttner R; Sihto H; Sundby Hall K; Eriksson M; Reichardt P; Joensuu H; Wardelmann E
PLoS One; 2018; 13(2):e0193048. PubMed ID: 29451912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
